Detection of Hepatitis C Virus in Paraffin–Embedded Liver Biopsies of Patients Negative for Viral Rna in Serum
Open Access
- 1 January 1999
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Hepatology
- Vol. 29 (1), 223-229
- https://doi.org/10.1002/hep.510290118
Abstract
The diagnosis of hepatitis C is based on serological testing for antibodies against various epitopes of the hepatitis C virus (HCV) and detection of HCV RNA in serum, because anti–HCV antibodies alone cannot discriminate patients who are infectious from those who have resolved the infection. If HCV RNA is not detected, which is the case in at least 20% of enzyme immunoassay (EIA)–positive patients, diagnosis remains unclear in a state of disease possibly well suited for therapeutic intervention. Therefore, we investigated if detection of HCV antigens or HCV RNA in routinely processed, formalin–fixed and paraffin–embedded (ffpe) liver biopsy specimens of patients positive for anti–HCV, but negative for HCV RNA in serum, could confirm diagnosis in this serological constellation. We detected HCV RNA by reverse–transcription polymerase chain reaction (RT–PCR) in 27 (61%) of 44 ffpe liver biopsies from EIA–positive, but HCV–RNA-seronegative, patients. Testing of 18 of these biopsies by a panel of polyclonal antibodies against structural and nonstructural HCV proteins revealed positive immunostaining in 6 cases (33%), which were also positive by RT–PCR. Most biopsies showed necroinflammation compatible with chronic hepatitis C, and the detection of tissue HCV RNA correlated significantly with a higher grade of inflammatory activity. Detectability of HCV RNA did not correlate with HCV subtype. In conclusion, the search for HCV RNA by RT–PCR within the liver biopsy specimen can establish rapid and unequivocal diagnosis of hepatitis C in at least 60% of anti–HCV antibody-positive patients who are seronegative for HCV RNA, and thus may help to avoid repeated testing and delayed therapy. Tissue RT–PCR may also be more efficient than serological testing for surveillance of interferon therapy response, because ongoing chronic active hepatitis C is clearly demonstrated in the absence of detectable serum HCV RNA.Keywords
This publication has 19 references indexed in Scilit:
- Hepatitis C virus: Epidemiology and transmissionHepatology, 1997
- Hepatitis C in a French population-based survey, 1994: Seroprevalence, frequency of viremia, genotype distribution, and risk factorsHepatology, 1997
- International collaborative study on the second EUROHEP HCV-RNA reference panelJournal of Virological Methods, 1996
- Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis CHepatology, 1995
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995
- Hepatocellular codistribution of c100, c33, c22, and NS5 hepatitis C virus antigens detected by using immunopurified polyclonal spontaneous human antibodiesHepatology, 1995
- Classification of chronic hepatitis: Diagnosis, grading and stagingHepatology, 1994
- The Natural History of Community-Acquired Hepatitis C in the United StatesNew England Journal of Medicine, 1992
- Hepatitis C virus antigen in hepatocytes: Immunomorphologic detection and identificationGastroenterology, 1992
- Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitisHepatology, 1991